PIONEERING A NEW ASSET CLASS IN HEALTH
Invest In The Future Of Psychedelic Medicine
A PORTFOLIO OF MARKET INNOVATING VENTURES
We’re proud to offer a large range of portfolios of integrated wellness assets in alternative medicine, supplements, and psychedelic pharmacology.
CREATED BY LEADERS FOR LEADERS
Directed by the world’s leading experts in psychedelic treatment, Auvega’s scientific advisory board is currently engaging leading universities and research teams.
WORLD-CHANGING IDEAS
Auvega is powered by innovation and exploring new and emergent markets in alternative medicine, supplements, and psychedelic pharmacology.
PREMIUM PLANT BASED SUPPLEMENTATION
Wellness Assets to fund advancements in Alternative Medicine, Supplements, and Psychedelic Pharmacology.
A PSYCHOACTIVE MEDICINE RENAISSANCE
322M
people suffer from depression worldwide
300M
people suffer from PTSD worldwide
164M
people suffer from substance abuse worldwide
1 in 5
American adults suffer from a form of mental illness
30.6%
of people affected by mass conflicts have PTSD
493%
increase in OUD diagnosis in the U.S. from 2010-2016
$1T
the estimated cost of depression to the global economy
$6T
estimated global cost of mental health conditions in 2030 by the World Economic Forum(up from $2.5 trillion in 2010)
115
people die every day from opioid abuse
RECENT PSYCHEDELIC TIMELINE
Over 7000 Years in the making
2020 – Jan
Santa Cruz, California decriminalized the cultivation and possession of psilocybin mushrooms, ayahuasca, peyote, and ibogaine.
2020-March
MindMed begin trading on the NEO Exchange under the symbol NEO:MMED. It was the world’s first publicly traded psychedelic pharmaceutical company.
2020 – Aug
Canadian Health Minister Patty Hajdu approved the use of psilocybin mushrooms for four people with incurable cancer. This was the first time that an exemption to the Controlled Drugs and Substances Act has been granted for the use of mushrooms.
2020 – Sep
Ann Arbor, Michigan became the third city in the United States to decriminalize all naturally-occurring psychedelic plants and fungi.
2020 – Oct
Canada Numinus Wellness Inc. harvested the first legal flush of psilocybin mushrooms by a public company under its Health Canada-issued Controlled Drugs and Substances Dealer’s License.
2020 – Nov
Washington, D.C. decriminalized the possession and cultivation of psychedelic plants and fungi.
Oregon legalized psilocybin for the mental health treatment of adults in supervised settings. It also decriminalized the possession of small amounts of street drugs, including psychedelics.
SUPPORTING & EMPOWERING THE JOURNEY TO WELLNESS.
Special Access for psilocybin & MDMA
Pending approval of regulatory change, Auvega Labs Inc. intends to support practitioners in helping their patients obtain Special Access to psychedelic-assisted therapies for a range of conditions and delivering these through the clinics.
Health Canada has posted its Notice of Intent, subject to public consultation, to revise its Special Access Program to allow legal access to psilocybin and MDMA outside clinical trials, while the substances await formal approvals.
Auvega Labs Inc. supports Health Canada’s leadership and stands in solidarity with the individuals and organizations who have advocated to increase safe and evidence-based accessibility. By working together and supporting evidence-based approaches to mental health, psychedelic-assisted psychotherapy can become a routine part of the healthcare system.
In The News
News Releases FOUNDERS CORPORATE UPDATE LETTER TO SHAREHOLDERS
July 7, 2022. Vancouver, B.C. – Auvega Labs Inc.; (the “Company” or “Auvega”) is pleased to announce…
Read More
In The News Congress to Vote on Psychedelics Research Amendments for Active Military Members
Congress to Vote on Psychedelics Research Amendments for Active Military Members
As is so often the…
Read More
In The News Investors Turning to Psychedelic Market as Renaissance Continues into New Wave of Diseases NEW YORK, Sept. 27, 2021 /PRNewswire/ — The emergence of psychedelic therapies as a popular investment…
Read More
In The News Drug Startup Raises $70 Million for Psychedelics Without a Trip (Bloomberg) — Delix Therapeutics Inc., a Boston-based company that’s researching compounds similar to…
Read More
In The News DMT Increases Growth Of Rat Neurons By 40 Percent, New Data Shows The psychedelic drug N,N-Dimethyltryptamine (DMT) has been found to stimulate the growth of rat neurons…
Read More
In The News Fund seeks to clear doubts about investing in psychedelic stocks – The Royal Gazette Asset managers professionals, angel VCs and others interested in learning and networking with industry…
Read More
In The News How Effective Is Fireside Project’s Psychedelic Hotline? New Study Aims To Find Out
The Fireside Project's Psychedelic Peer Support Line launched in April. The non-profit organization…
Read More
In The News Research Points to Benefits of Psychedelics and Alternative Medicines Earlier this month, the World Health Organization came out with a report on depression, saying it's common…
Read More
In The News OPINION: Magic Mushrooms for Mental Health — The Complex Future of Psychedelic Therapies by Sarah Stuteville
I have experienced mental health challenges for most of my life. My first panic…
Read More
In The News Psychedelics May Help Reduce Mental Health Impact Of COVID-19 Pandemic In addition to the threat to physical health COVID-19 poses, the psychological impact of the pandemic…
Read More